Research

Micronutrients & recovery

Immune-modulating nutrition (supplementation with glutamine, arginine, omega-3 fatty acids, and antioxidants) does not improve outcomes in general critically ill patients and may increase mortality, although it may benefit specific subgroups like severe burn patients.

Do not routinely use immune-modulating supplements (glutamine, arginine, omega-3s) for general critically ill patients. These supplements have been shown to increase mortality or provide no benefit in large trials. They may be considered for specific subgroups like severe burn patients, but this requires specialist judgment.

GoodRefutesHIGH confidence
The REDOXS trial showed an increase in mortality with high doses of enteral and parenteral glutamine... The OMEGA trial showed that enteral supplementation of n-3 fatty acids... did not improve the primary endpoint... and might be harmful.
Yaseen M. Arabi et al. · Intensive Care Medicine · 2017

Why this rating

Supported by multiple large RCTs (REDOXS, OMEGA, MetaPlus) and meta-analyses.

Source

The intensive care medicine research agenda in nutrition and metabolism

Yaseen M. Arabi et al. · Intensive Care Medicine · 2017

narrative_reviewCited 209×
Read the paper

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →